NASDAQ Companies

On track to initiate Phase 1b/2 etigilimab (Anti-TIGIT) combination study in Q4 2020Enrolment resumed in Phase 2 study of alvelestat […]

Non-dilutive committed capital extends cash runway into at least 2024Facility strengthens balance sheet through anticipated commercial launches of Axsome’s two […]

BEIJING, Sept. 29, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the […]

DENVER, Sept. 29, 2020 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV), the Colorado-based omni-channel sales and distribution company with a […]

LONDON, Sept. 29, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully […]

HOUSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) — U.S. Energy Corp. (NASDAQCM: USEG) (“U.S. Energy” or the “Company”) today announced that […]

Tuebingen, Germany and Houston, Texas, September 29, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in […]

BAKERSFIELD, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ:LGIH) today announced their entrance into the Bakersfield, California market […]

Summit Therapeutics Inc.(‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and […]

Heidelberg, Germany, September 29, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]